These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New insights into drug resistance in cancer. Ojima I; Ferlini C Chem Biol; 2003 Jul; 10(7):583-4. PubMed ID: 12890528 [TBL] [Abstract][Full Text] [Related]
4. Drug resistance: a growing problem. Peet NP Drug Discov Today; 2010 Aug; 15(15-16):583-6. PubMed ID: 20434584 [No Abstract] [Full Text] [Related]
6. [Progress in the study of targeted drug delivery systems for cancer stem cells]. Qiao MX; Zhang XJ; Shuang BA; Hu HY; Zhao XL; Chen DW Yao Xue Xue Bao; 2013 Apr; 48(4):477-83. PubMed ID: 23833932 [TBL] [Abstract][Full Text] [Related]
7. Drug Delivery Nanoparticles in Treating Chemoresistant Tumor Cells. Barrera G; Daga M; Ferrara B; Dianzani C; Pizzimenti S; Argenziano M; Cavalli R; Trotta F Curr Med Chem; 2017; 24(42):4800-4815. PubMed ID: 27919217 [TBL] [Abstract][Full Text] [Related]
8. Toward a Better Understanding of the Complexity of Cancer Drug Resistance. Gottesman MM; Lavi O; Hall MD; Gillet JP Annu Rev Pharmacol Toxicol; 2016; 56():85-102. PubMed ID: 26514196 [TBL] [Abstract][Full Text] [Related]
9. The role of galectin-3 in cancer drug resistance. Fukumori T; Kanayama HO; Raz A Drug Resist Updat; 2007 Jun; 10(3):101-8. PubMed ID: 17544840 [TBL] [Abstract][Full Text] [Related]
10. Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers. Dawar S; Singh N; Kanwar RK; Kennedy RL; Veedu RN; Zhou SF; Krishnakumar S; Hazra S; Sasidharan S; Duan W; Kanwar JR Drug Discov Today; 2013 Dec; 18(23-24):1292-300. PubMed ID: 24055842 [TBL] [Abstract][Full Text] [Related]
11. Transport Barriers and Oncophysics in Cancer Treatment. Nizzero S; Ziemys A; Ferrari M Trends Cancer; 2018 Apr; 4(4):277-280. PubMed ID: 29606312 [TBL] [Abstract][Full Text] [Related]
12. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance]. Chen JN; Shen Q; Li SS Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of tumor endothelial cells and drug delivery. Hida K; Maishi N; Sakurai Y; Hida Y; Harashima H Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):140-147. PubMed ID: 26626622 [TBL] [Abstract][Full Text] [Related]
14. Clinical cancer research 2001: new agents and therapies. Verweij J; de Vries EG Drug Resist Updat; 2001 Aug; 4(4):217-23. PubMed ID: 11991676 [No Abstract] [Full Text] [Related]
16. Combinatorial application of nucleic acid-based agents targeting protein kinases for cancer treatment. Spänkuch B; Strebhardt K Curr Pharm Des; 2008; 14(11):1098-112. PubMed ID: 18473857 [TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy for malignant tumors: problems and prospects]. Orlova RV; Vaizyan RI; Ivanova AK; Tikhonova EK; Zorina EY Vopr Onkol; 2015; 61(2):244-51. PubMed ID: 26087606 [TBL] [Abstract][Full Text] [Related]
18. Can a nanoparticle that mimics Salmonella effectively combat tumor chemotherapy resistance? Mercado-Lubo R; McCormick BA Nanomedicine (Lond); 2017 Apr; 12(7):705-710. PubMed ID: 28322607 [No Abstract] [Full Text] [Related]
19. Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy. Hussain Z; Arooj M; Malik A; Hussain F; Safdar H; Khan S; Sohail M; Pandey M; Choudhury H; Ei Thu H Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1015-1024. PubMed ID: 29873531 [TBL] [Abstract][Full Text] [Related]
20. Nanoparticle approaches to combating drug resistance. Moon JH; Moxley JW; Zhang P; Cui H Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]